 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 8 | 1/1 | 返回列表 |
| 查看: 1476 | 回復: 7 | |||
luwangxing金蟲 (正式寫手)
|
[交流]
【轉(zhuǎn)帖】國產(chǎn)PVP遭遇FDA發(fā)難，過氧化物超標 已有5人參與
|
|
原文：http://www.fda.gov/drugs/drugsafety/ucm230492.htm 博愛新開源算是國內(nèi)PVP較為主要的供應(yīng)商吧 過氧化物超標4倍 CP05，和CP10沒有檢查該項目 Advisory to Drug and Dietary Supplement Manufacturers, Compounding Pharmacies and Distributors of Excipients and Dietary Ingredients – FDA Detects High Levels of Peroxide in Crospovidone [10-21-2010] The U.S. Food and Drug Administration is alerting drug and dietary supplement manufacturers, compounding pharmacies, and distributors of Povidone analogs (Povidone/Copovidone/Crospovidone), that the agency recently detected excessive levels of peroxide in one lot of Crospovidone (cross linked polyvinyl N-pyrrolidone) manufactured by China-based Tianjin Boai NKY International Ltd1. The peroxide level found by the FDA in the lot was more than four (4) times the maximum level of peroxide (400 ppm) allowed by global compendial monographs. Other lots of Povidone analogs2 manufactured by this firm may also contain excessive levels of peroxide. An Import Alert has been issued to prevent further entry of Tianjin Boai NKY International Ltd Crospovidone into the U.S. market. To date, the FDA is not aware of any illnesses in the United States stemming from peroxide contamination. The level of peroxide found in this particular lot does not appear, on its own, to pose a significant health risk in drugs or dietary supplements. The FDA nonetheless remains concerned that elevated levels of peroxide can cause subpotent finished products. Crospovidone is a very common ingredient in drugs and dietary supplements. Peroxide is a potential impurity from the polymerization step involved in the manufacturing of Povidone analogs. Residual peroxide levels of <100 ppm have been reported to cause oxidative degradation.3 The FDA is concerned that drug manufacturers using excipients containing high levels of peroxides will observe a loss of drug potency and the formation of excessive impurities during the product shelf life. It is essential that users and distributors implement robust supplier management programs to assure that peroxide levels in Povidone analogs are in control for each batch received. Manufacturers using such excipients should employ sound risk management principles in establishing appropriate scrutiny (including peroxide testing regimen) and actions to take for a given supplier, including but not limited to the following: ( a ) review supplier history, including any relevant information on manufacturing reliability; ( b ) assess peroxide levels obtained from testing4 of past batches of Povidone analogs; ( c ) determine reliability of results reported on Certificates of Analysis; ( d ) consider information obtained from ongoing communications with suppliers; and ( e ) determine whether the quality of any finished product has been impacted. Manufacturers who use ingredients that might contain elevated levels of peroxide are advised to notify the FDA if they become aware of any further findings of quality problems or potentially related adverse events. 1 May also do business as Friends Union Enterprise (Jianjin) Ltd, Boai New Kaiyuan Pharmaceutical Company, Boai NKY Pharmaceuticals Ltd or Bluetech Chemicals Limited. 2 A recently published study also found elevated levels of peroxide in multiple lots of Povidone analogs, consistent with the FDA’s findings. (Silverstein, PhD, Irwin, Pharmaceutical Technology, Vol. 33, Issue 10, pp. 84-88, October 02, 2009. “The Case for Supplier Qualification.”) 3 Hartauer, et al, Pharm. Dev. Technol. 2000;5(3):303-10. “Influence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: identification and control of an oxidative degradation product.” 4 A peroxide test is not currently listed in the USP monographs for crospovidone and povidone. However, a non-specific USP/EP method (see Copovidone NF) can be used to readily detect peroxide present at 400 ppm in Povidone analogs. Alternatively, a validated method shown to be specific for peroxide and having at least the same sensitivity as the compendial method may be used. For import alert information, please see: http://www.accessdata.fda.gov/cms_ia/importalert_189.html 這是我在sfda網(wǎng)站看到的。據(jù)我所知，巴斯夫的交聯(lián)吡咯烷酮的COA中有這一項指標，標準是不大于400ppm。 |
回復此樓» 猜你喜歡
271材料工程求調(diào)劑
已經(jīng)有5人回復
-
281求調(diào)劑（0805）
已經(jīng)有16人回復
-
304求調(diào)劑
已經(jīng)有6人回復
-
材料工程專碩調(diào)劑
已經(jīng)有6人回復
-
一志愿天大材料與化工（085600）總分338
已經(jīng)有4人回復
-
085700資源與環(huán)境308求調(diào)劑
已經(jīng)有3人回復
-
求材料調(diào)劑
已經(jīng)有8人回復
-
294求調(diào)劑材料與化工專碩
已經(jīng)有5人回復
-
一志愿華中科技大學，080502，354分求調(diào)劑
已經(jīng)有4人回復
-
一志愿吉林大學材料學碩321求調(diào)劑
已經(jīng)有6人回復
» 本主題相關(guān)價值貼推薦，對您同樣有幫助:
- 轉(zhuǎn)：具有全新降低血糖機制的新藥被fda專家小組否定
已經(jīng)有3人回復
tjegg
鐵桿木蟲 (著名寫手)
- 應(yīng)助: 26 (小學生)
- 金幣: 6869.3
- 紅花: 16
- 帖子: 2615
- 在線: 448小時
- 蟲號: 338983
- 注冊: 2007-04-05
- 性別: GG
- 專業(yè): 抗腫瘤藥物藥理
2樓2010-10-26 10:31:59
reallove2935
禁言 (著名寫手)
★
小木蟲(金幣+0.5):給個紅包，謝謝回帖交流
小木蟲(金幣+0.5):給個紅包，謝謝回帖交流
|
本帖內(nèi)容被屏蔽 |
3樓2010-10-26 14:03:00
tjegg
鐵桿木蟲 (著名寫手)
- 應(yīng)助: 26 (小學生)
- 金幣: 6869.3
- 紅花: 16
- 帖子: 2615
- 在線: 448小時
- 蟲號: 338983
- 注冊: 2007-04-05
- 性別: GG
- 專業(yè): 抗腫瘤藥物藥理
4樓2010-10-26 15:04:13
5樓2010-10-26 16:26:16
reallove2935
禁言 (著名寫手)
|
本帖內(nèi)容被屏蔽 |
6樓2010-10-28 09:01:32
meteord
木蟲 (正式寫手)
- 應(yīng)助: 17 (小學生)
- 金幣: 5330.2
- 散金: 68
- 紅花: 1
- 帖子: 436
- 在線: 192.9小時
- 蟲號: 862641
- 注冊: 2009-10-04
- 性別: GG
- 專業(yè): 藥劑學
7樓2010-10-28 09:15:57
zblyyk
金蟲 (小有名氣)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 1216.1
- 帖子: 246
- 在線: 54小時
- 蟲號: 921166
- 注冊: 2009-12-06
- 性別: GG
- 專業(yè): 藥劑學
8樓2010-11-06 14:39:38
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 luwangxing 的主題更新
| 8 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 321求調(diào)劑 +3 | 何潤采123 2026-03-18 | 3/150 |
|
|---|---|---|---|---|
|
|
[考研] 274求調(diào)劑 +5 | S.H1 2026-03-18 | 5/250 |
|
|
|
[考研] 344求調(diào)劑 +6 | knight344 2026-03-16 | 7/350 |
|
|
[考研] 085600材料與化工 +5 | 安全上岸！ 2026-03-16 | 5/250 |
|
|
|
[考研] 0703化學調(diào)劑 ，六級已過，有科研經(jīng)歷 +10 | 曦熙兮 2026-03-15 | 10/500 |
|
|
|
[考研] 312求調(diào)劑 +8 | 陌宸希 2026-03-16 | 9/450 |
|
|
|
[考研] 303求調(diào)劑 +4 | 睿08 2026-03-17 | 6/300 |
|
|
|
[考研] 293求調(diào)劑 +11 | zjl的號 2026-03-16 | 16/800 |
|
|
|
[考研] 考研求調(diào)劑 +3 | 橘頌. 2026-03-17 | 4/200 |
|
|
|
[考研] 277調(diào)劑 +5 | 自由煎餅果子 2026-03-16 | 6/300 |
|
|
|
[考研] 梁成偉老師課題組歡迎你的加入 +8 | 一鴨鴨喲 2026-03-14 | 10/500 |
|
|
|
[考研] 070300化學學碩求調(diào)劑 +6 | 太想進步了0608 2026-03-16 | 6/300 |
|
|
|
[考研] 中科院材料273求調(diào)劑 +4 | yzydy 2026-03-15 | 4/200 |
|
|
|
[考研] 070303 總分349求調(diào)劑 +3 | LJY9966 2026-03-15 | 5/250 |
|
|
|
[考研]
 機械專碩調(diào)劑
+3
|
笨笨兔子 2026-03-12 | 3/150 |
|
|
|
[考研] 070305求調(diào)劑 +3 | mlpqaz03 2026-03-14 | 4/200 |
|
|
|
[考研] 330求調(diào)劑 +3 | ?醬給調(diào)劑跪了 2026-03-13 | 3/150 |
|
|
|
[考研] ［0860］321分求調(diào)劑，ab區(qū)皆可 +4 | 寶貴熱 2026-03-13 | 4/200 |
|
|
|
[考研] 281求調(diào)劑 +9 | Koxui 2026-03-12 | 11/550 |
|
|
|
[考研] 26調(diào)劑/材料科學與工程/總分295/求收留 +9 | 2026調(diào)劑俠 2026-03-12 | 9/450 |
|